NASDAQ
Total Transactions
5
1 buys /4 sells
Shares Acquired
12,000
Transactions: 1•Avg: 12,000
Shares Disposed
26,712
Transactions: 4•Avg: 6,678
Net Activity
-14,712
Net Selling•Ratio: 25%
Q4 2025(Current) | 12,000 | 26,712 | -14,712 | 25.00% |
Q3 2025 | 25,000 | 76,479 | -51,479 | 12.50% |
Q2 2025 | 20,725 | 53,836 | -33,111 | 25.00% |
Q1 2025 | 630,508 | 164,387 | +466,121 | 150.00% |
Q4 2024 | 238,706 | 502,769 | -264,063 | 47.37% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 14,712 shares•Acquired/Disposed Ratio: 25%
Net Activity | |||||
|---|---|---|---|---|---|
PDVPD PATEL DINESH V PH D | Director, officer: president and ceo | 22 | 381,999 | 221,996 | +160,003 |
GS Gupta Suneel | Officer: chief development officer | 12 | 205,450 | 328,078 | -122,628 |
WWD Waddill William D. | Director | 15 | 39,714 | 68,000 | -28,286 |
AA Ali Asif | Officer: chief financial officer | 16 | 107,202 | 81,683 | +25,519 |
SHE SELICK HAROLD E | Director | 4 | 22,439 | 10,725 | +11,714 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-11-21 | Director, officer: president and ceo | Sale | 440 | $0 | $0 | 519,543 | |
2025-11-17 | Officer: chief medical officer | Sale | 2,712 | $84.77 | $229,896.24 | 81,180 | |
2025-10-10 | Director | Purchase | 12,000 | $6.98 | $83,760 | 17,130 | |
2025-10-10 | Director | Sale | 4,000 | $69.25 | $277,000 | 13,130 | |
2025-10-10 | Director | Sale | 8,000 | $87.81 | $702,480 | 5,130 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
PDVPD PATEL DINESH V PH D | Director, officer: president and ceo | Nov 24, 2025 | |
MAM MOLINA ARTURO MD | Officer: chief medical officer | Nov 19, 2025 | |
WWD Waddill William D. | Director | Oct 14, 2025 | |
WWD Waddill William D. | Director | Oct 14, 2025 | |
WWD Waddill William D. | Director | Oct 14, 2025 |
Net change in shares shown on right
No price data available for this timeframe.